Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alteryx, Inc. Class A Common Stock (NY: AYX )

N/A UNCHANGED
Last Price Updated: 7:00 PM EDT, Mar 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alteryx, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Missed Out on Alphabet? My Best Artificial Intelligence Stock To Buy and Hold.
Palantir depends heavily on AI to deliver insights. 
Via The Motley Fool
Why Alteryx Stock Was Gaining Today
A product enhancement and broad market tailwinds lifted the software stock. 
Via The Motley Fool
Alteryx Will Gain From Democratization Of Data and Self-Service Analytics, Analyst Says While Bumping Up Price Target By 18%
Via Benzinga
10 Information Technology Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
10 Analysts Have This to Say About Alteryx
  Over the past 3 months, 10 analysts have published their opinion on Alteryx (NYSE:AYX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Analyst Ratings for Alteryx
Within the last quarter, Alteryx (NYSE:AYX) has observed the following analyst ratings: 
Via Benzinga
Where Alteryx Stands With Analysts
Within the last quarter, Alteryx (NYSE:AYX) has observed the following analyst ratings: 
Via Benzinga
Analysis of Alteryx’s Trifacta Acquisition
Recently, Alteryx announced its acquisition of Trifacta for an estimated $400 million. 
Via Talk Markets
This Analyst Raises PT On Karuna Therapeutics By 100%; Wells Fargo Predicts $2,300 For This Stock
Piper Sandler boosted the price target on First Solar, Inc. (NASDAQ: FSLR) from $120 to $165. Piper Sandler analyst Kashy Harrison maintained an Overweight rating on the stock. First Solar shares rose... 
Via Benzinga
Moderna, PayPal And Some Other Big Gainers From Wednesday
U.S. stocks closed higher on Wednesday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. 
Via Benzinga
Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday. 
Via Benzinga
Needham Maintains Buy Rating for Alteryx: Here's What You Need To Know
Needham has decided to maintain its Buy rating of Alteryx (NYSE:AYX) and raise its price target from $57.00 to $68.00. Shares of Alteryx are trading up 20.48% over the last 24 hours, at $60.92 per... 
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday. 
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Alteryx: Q2 Earnings Insights
Alteryx (NYSE:AYX) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Alteryx beat estimated earnings by... 
Via Benzinga
Where Alteryx Stands With Analysts
Over the past 3 months, 6 analysts have published their opinion on Alteryx (NYSE:AYX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
Where Alteryx Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Alteryx (NYSE:AYX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investors! Another busy day of trading awaits and with that comes our biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
Alteryx Builds on Trifacta Acquisition to Target Enterprise Sales
Data science and analytics platform provider is stepping up its focused sales approach to drive the adoption of its products within the larger enterprise segment. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
Via Benzinga
10 Information Technology Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Looking Into Alteryx's Return On Capital Employed
Alteryx (NYSE:AYX) brought in sales totaling $157.94 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 181.17%, resulting in a loss of $105.57 million. 
Via Benzinga
Here's How Rosenblatt Views Alteryx, Datadog, Dynatrace Ahead Of Earnings
Rosenblatt offers its insight on three tech stocks ahead of their earnings results in May. Alteryx, Inc (NYSE: AYX) will report Q1 results on May 3. Rosenblatt believes that... 
Via Benzinga
56 Biggest Movers From Yesterday
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead... 
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) jumped 52.8% to $2.0478. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral... 
Via Benzinga
Alteryx's Return on Invested Capital Overview
According to data from Benzinga Pro, during Q4, Alteryx's (NYSE:AYX) reported sales totaled $173.81 million. Despite a 35.31% increase in earnings, the company posted a loss of $37.55 million. 
Via Benzinga
Read How Analysts Reacted To Alteryx's Q4 Results
Analysts had mixed opinions on Alteryx Inc (NYSE: AYX) post Q4 beat. Alteryx is a software company that provides self-service data analytics software. Oppenheimer... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.